Cargando…
The molecular etiology and treatment of glucocorticoid-induced osteoporosis
Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis, accounting for 20% of osteoporosis diagnoses. Using glucocorticoids for >6 months leads to osteoporosis in 50% of patients, resulting in an increased risk of fracture and death. Osteoblasts, osteocytes,...
Autores principales: | Peng, Cheng-Huan, Lin, Wen-Ying, Yeh, Kuang-Ting, Chen, Ing-Ho, Wu, Wen-Tien, Lin, Ming-Der |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323641/ https://www.ncbi.nlm.nih.gov/pubmed/34386357 http://dx.doi.org/10.4103/tcmj.tcmj_233_20 |
Ejemplares similares
-
Zebrafish models for glucocorticoid-induced osteoporosis
por: Lin, Wen-Ying, et al.
Publicado: (2022) -
An anatomical study of the proximal aspect of the medial femoral condyle to define the proximal-distal condylar length
por: Chang, Chia-Ming, et al.
Publicado: (2017) -
The adductor tubercle can be a radiographic landmark for joint line position determination: an anatomic-radiographic correlation study
por: Yeh, Kuang-Ting, et al.
Publicado: (2019) -
The critical role of T cells in glucocorticoid-induced osteoporosis
por: Song, Lin, et al.
Publicado: (2020) -
Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015)